Protagonist Therapeutics Inc (PTGX) — Working Capital to Net Assets Ratio
Protagonist Therapeutics Inc (PTGX) has a Working Capital to Net Assets ratio of 83.9% as of September 2025. Working capital of $541.48 Million (current assets of $586.42 Million minus current liabilities of $44.94 Million) is measured against net assets of $645.44 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See PTGX net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Protagonist Therapeutics Inc Working Capital to Net Assets (2014–2024)
This chart shows how Protagonist Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 11 annual periods from 2014 to 2024. As of September 2025, the ratio stands at 83.9%, reflecting working capital of $541.48 Million against net assets of $645.44 Million USD. Check PTGX goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Protagonist Therapeutics Inc (2014–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Protagonist Therapeutics Inc from 2014 to 2024, covering 11 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see PTGX market cap overview.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 80.6% | $544.24 Million | $675.29 Million | $591.64 Million | $47.40 Million | ▼ -18.7 pp |
| 2023 | 99.3% | $334.30 Million | $336.68 Million | $355.58 Million | $21.27 Million | ▲ +1.0 pp |
| 2022 | 98.3% | $211.90 Million | $215.61 Million | $243.08 Million | $31.18 Million | ▼ -0.6 pp |
| 2021 | 98.9% | $296.72 Million | $300.02 Million | $340.74 Million | $44.02 Million | ▲ +0.4 pp |
| 2020 | 98.5% | $275.37 Million | $279.61 Million | $315.61 Million | $40.24 Million | ▼ -39.0 pp |
| 2019 | 137.4% | $109.91 Million | $79.96 Million | $145.31 Million | $35.41 Million | ▲ +38.5 pp |
| 2018 | 99.0% | $111.34 Million | $112.52 Million | $137.50 Million | $26.16 Million | ▲ +9.1 pp |
| 2017 | 89.9% | $108.39 Million | $120.63 Million | $150.95 Million | $42.55 Million | ▲ +2.1 pp |
| 2016 | 87.7% | $76.81 Million | $87.56 Million | $83.24 Million | $6.43 Million | ▼ -27.7 pp |
| 2015 | 115.5% | $11.08 Million | $9.60 Million | $14.21 Million | $3.13 Million | ▲ +7.8 pp |
| 2014 | 107.6% | $8.56 Million | $7.96 Million | $9.91 Million | $1.35 Million | — |